MedPath

Cognitive Behavioral Therapy for Insomnia: Face-to-Face Versus Telemedicine

Not Applicable
Completed
Conditions
Insomnia
Registration Number
NCT03293745
Lead Sponsor
University of Michigan
Brief Summary

The purpose of this study is to compare the effectiveness of Cognitive-Behavioral Therapy (CBT) for insomnia conducted face-to-face with a therapist versus CBT for insomnia conducted using Internet-based videoconference technology.

Detailed Description

The objective of this clinical trial is to compare the effectiveness of telemedicine Cognitive-Behavioral Therapy (CBT) for insomnia \[via the American Academy of Sleep Medicine Sleep Telemedicine (AASM Sleep TM) platform\] to gold standard face-to-face CBT for insomnia. The central hypothesis is that CBT for insomnia delivered by AASM SleepTM will be comparable to face-to-face CBT for insomnia for clinical outcomes and patient satisfaction, but AASM SleepTM will be a more cost effective treatment modality (primarily through reduced costs associated with facility use and patient time). The rationale for the proposed project is rooted in the critical need to disseminate CBT for insomnia using the most effective and efficient modalities, with recognition that therapist involvement likely produces the most favorable outcomes.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
65
Inclusion Criteria
  1. Current diagnosis of insomnia
Exclusion Criteria
  1. Suspicion of or inadequately treated sleep disorder other than insomnia
  2. Presence of psychiatric disorders for which CBT for insomnia may be contraindicated
  3. Unstable chronic medical condition directly related to insomnia
  4. Routine overnight shift work
  5. Previous failed adequate trial of CBT for insomnia
  6. Unstable dose of sleep medications
  7. Lack of access to reliable WiFi connection in the home

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in Insomnia Severity Index (ISI)Baseline, post-treatment (about 6 weeks), follow-up (about 12-weeks post-treatment)

The ISI is a 7-item questionnaire assessing the nature, severity, and impact of sleep problems, with good psychometric properties and sensitivity to change with treatment 0-7 = No clinically significant insomnia 8-14 = Subthreshold insomnia 15-21 = Clinical insomnia (moderate severity) 22-28 = Clinical insomnia (severe)

Secondary Outcome Measures
NameTimeMethod
Client Satisfaction Questionnaire (CSQ-8)Post-treatment (about 6 weeks)

The CSQ-8 is an 8-item, easily scored and administered measurement that is designed to measure client satisfaction with services. The items for the CSQ-8 were selected on the basis of ratings by mental health professionals of a number of items that could be related to client satisfaction and by subsequent factor analysis. The CSQ-8 is unidimensional, yielding a homogeneous estimate of general satisfaction with services.

Scores range from 8 - 32, with high scores indicating greater satisfaction.

Change in Therapy Evaluation Questionnaire (TEQ)Baseline, post-treatment (about 6 weeks), follow-up (about 12-weeks post-treatment)

The TEQ is a 7-item scale with 5 questions to assess perceived logic of and confidence in treatment, willingness to repeat treatment, and the likelihood that the treatment will help others and 2 questions assessing therapist warmth and competence.

Trial Locations

Locations (1)

University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

University of Michigan
🇺🇸Ann Arbor, Michigan, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.